Adaptimmune Therapeutics plc

ADAPY ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jan 15, 2025
SCHEDULE 13G/A Jan 8, 2025
8-K Dec 19, 2024 8-K
SCHEDULE 13G/A Dec 5, 2024
10-Q Nov 13, 2024 10-Q
8-K Nov 13, 2024 8-K
8-K Nov 13, 2024 8-K
SC 13G/A Nov 13, 2024 ADAPTIMMUNE THERAPEUTICS PLC
8-K Nov 1, 2024 8-K
8-K Sep 23, 2024 8-K
10-Q Aug 12, 2024 10-Q
8-K Aug 12, 2024 8-K
8-K Aug 2, 2024 FORM 8-K
8-K Jul 16, 2024 8-K
4 Jul 1, 2024 4
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jun 18, 2024 OWNERSHIP DOCUMENT
8-K Jun 11, 2024 8-K
8-K May 30, 2024 8-K
← Newer Page 4 of 33 · 808 filings Older →